Loại tài liệu:    Chỉ tìm trong: 
381-390 trong số 512 kết quả
Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancer
Tác giả: Xiaomeng Xie, Young Ran Shin, Tae-Sung Kim, Yeon-Sun Seong, Yong Weon Yi, Dong Joon Kim
Xuất bản: United States: American journal of cancer research , 2025
Bộ sưu tập: NCBI
ddc:  230.0071
 
A novel reduced toxicity conditioning regimen for older myelodysplastic neoplasms patients undergoing haploidentical stem cell transplantation: a prospective cohort study
Tác giả: Wen-Jing Yu, Yu-Qian Sun, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Dong Mo, Meng Lv, Xiao-Jun Huang, Yu Wang
Xuất bản: United States: American journal of cancer research , 2025
Bộ sưu tập: NCBI
ddc:  025.313
 
Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report
Tác giả: Guangjian Yang, Jiaqi Hu, Runze Liu, Pei Li, Linke Yang, Xiaoyong Tang, Luokun Wang
Xuất bản: England: Anti-cancer drugs , 2025
Bộ sưu tập: NCBI
ddc:  612.8262
 
Efficacy and safety of first-line immunotherapy-based regimens for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis
Tác giả: Wengang Zhang, Wencheng Zhao, Hao Wang, Yayi He, Xinyu Zhang, Zhiyi Guo, Li Ye, Zhimin Chen, Kandi Xu, Lishu Zhao, Xinyue Liu, Yujin Liu
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc:  232.908
 
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancer
Tác giả: Runze Li, Zhifei Li, Peng Li, Jianchuan Chen, Bin Qiu, Fengwei Tan, Qi Xue, Shugeng Gao, Jie He
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc:  353.63
 
Video-assisted mediastinocopic lymphadenectomy (VAMLA) for restaging clinical N2-3 non-small cell lung cancer (NSCLC) after neoadjuvant treatment
Tác giả: Nina Reig-Oussedik, Sergi Call, Carme Obiols, Bruno Garcia-Cabo, José Sanz-Santos, Lucía Reyes Cabanillas-Paredes, Juan Manuel Ochoa-Alba, Mireia Serra-Mitjans, Ramón Rami-Porta
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
Tác giả: Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc:  133.5266
 
Transformation from acquired EGFR 19del/C797S to EGFR 19del/T790M in an advanced non-small cell lung cancer patient: a case report and literature review
Tác giả: Xianhuai Jin, Yaping Quan, Jiao Liu, Yong Hu, Hao Li
Xuất bản: England: Anti-cancer drugs , 2025
Bộ sưu tập: NCBI
ddc:  025.313
 
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Tác giả: Guido Ghilardi, Zainul S Hasanali, Sandra P Susanibar-Adaniya, Lena E Winestone, Marco Ruella, Alfred L Garfall
Xuất bản: England: Journal for immunotherapy of cancer , 2025
Bộ sưu tập: NCBI
ddc:  382.1
 
Efficacy and safety of anlotinib plus EGFR tyrosine kinase inhibitors in slow- or locally progressing non-small cell lung cancer after adjuvant therapy
Tác giả: Jiayue Ye, Masaya Aoki, Jian Hu, Jiacong Liu, Wang Lv, Yucheng Ma, Luming Wang, Pinghui Xia, Wenzhen Xu, Yuhong Yang, Linhai Zhu
Xuất bản: China: Translational lung cancer research , 2025
Bộ sưu tập: NCBI
ddc:  496.3616
 

Truy cập nhanh danh mục